Quantification of myocardial iron deposition by two-dimensional speckle tracking in patients with β-thalassaemia major and Blackfan-Diamond anaemia

Heart

Volumn 97, Issue 5, 2011, Pages 388-393

  Garceau, P ^a   Nguyen, E T ^a   Carasso, S ^a   Ross, H ^a   Pendergrast, J ^a   Moravsky, G ^a   Bruchal Garbicz, B ^a   Rakowski, Harry ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IRON;

ADULT; ARTICLE; BETA THALASSEMIA; BLACKFAN DIAMOND ANEMIA; BLOOD TRANSFUSION; CLINICAL ARTICLE; COMPARATIVE STUDY; CORRELATION ANALYSIS; ECHOCARDIOGRAPHY; FEMALE; HEART MUSCLE; HUMAN; IRON OVERLOAD; LONG TERM CARE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS;

ADULT; ANEMIA, DIAMOND-BLACKFAN; BETA-THALASSEMIA; CASE-CONTROL STUDIES; DIASTOLE; ECHOCARDIOGRAPHY; FEMALE; HUMANS; IRON; IRON OVERLOAD; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MYOCARDIUM; OBSERVER VARIATION; STRESS, PHYSIOLOGICAL; STROKE VOLUME; SYSTOLE;

EID: 79751489081     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2010.192641     Document Type: Article

References (35)

1. Aessopos A, Berdoukas V, Tsironi M. The heart in transfusion dependent homozygous thalassaemia today - prediction, prevention and management. Eur J Haematol 2008;80:93-106.
2. Wood JC, Tyszka JM, Carson S, et al. Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease. Blood 2004;103:1934-6. (Pubitemid 38268994)
3. Borgna-Pignatti C, Cappellini MD, De Stefano P, et al. Survival and complications in thalassemia. Ann N Y Acad Sci 2005;1054:40-7. (Pubitemid 43031009)
4. Wood JC. Cardiac iron across different transfusion-dependent diseases. Blood Rev 2008;22(Suppl 2):S14-21.
5. Davis BA, Porter JB. Long-term outcome of continuous 24-hour deferoxamine infusion via indwelling intravenous catheter in high-risk beta-thalassemia. Blood 2000;95:1229-36. (Pubitemid 30099831)
6. Pennell DJ, Berdoukas V, Karagiorga M. Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis. Blood 2006;107:3738-44.
7. Bosi G, Crepaz R, Gamberini MR, et al. Left ventricular remodelling and systolic and diastolic function in young adults with beta-thalassemia major: a Doppler echocardiographic assessment and correlation with hematological data. Heart 2003;89:762-6. (Pubitemid 36760638)
8. Hahalis G, Manolis AS, Gerasimidou I, et al. Right ventricular diastolic function in beta-thalassemia major: echocardiographic and clinical correlates. Am Heart J 2001;141:428-34. (Pubitemid 32200272)
9. Nienhuis AW, Griffith P, Strawczynski H, et al. Evaluation of cardiac function in patients with thalassemia major. Ann N Y Acad Sci 1980;344:384-96. (Pubitemid 11140748)
10. Leonardi B, Margossian R, Colan SD, et al. Relationship of magnetic resonance imaging estimation of myocardial iron to left ventricular systolic and diastolic function in thalassemia. JACC Cardiovasc Imaging 2008;1:572-8.
11. Westwood MA, Firmin DN, Gildo M, et al. Intercentre reproducibility of magnetic resonance T2* measurements of myocardial iron in thalassaemia. Int J Cardiovasc Imaging 2005;21:531-8. (Pubitemid 41435154)
12. Tanner MA, He T, Westwood MA, et al; Thalassemia International Federation Heart T2* Investigators. Multi-center validation of the transferability of the magnetic resonance T2* technique for the quantification of tissue iron. Haematologica 2006;91:1388-91.
13. Ghugre NR, Enriquez CM, Gonzalez I, et al. MRI detects myocardial iron in the human heart. Magn Reson Med 2006;56:681-6. (Pubitemid 44338890)
14. Anderson LJ, Holden S, Davis B, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001;22:2171-9. (Pubitemid 33139463)
15. Magri D, Sciomer S, Fedele F, et al. Early imapirment of myocardial function in young patients with B-thalassemia major. Eur J Haematol 2008;80:515-22. (Pubitemid 351677458)
16. Hamdy AM. Use of strain and tissue velocity imaging for early detection of regional myocardial dysfunction in patients with beta thalassemia. Eur J Echocardiogr 2007;8:102-9. (Pubitemid 46112120)
17. Nagueh SF, Appleton CP, Gillebert TC, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 2009;22:107-33.
18. Nagueh SF, Middleton KJ, Kopelen HA, et al. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997;30:1527-33. (Pubitemid 27486472)
19. Pirat B, Khoury DS, Hartley CJ, et al. A novel feature-tracking echocardiographic method for the quantitation of regional myocardial function: validation in an animal model of ischemia-reperfusion. J Am Coll Cardiol 2008;51:651-9. (Pubitemid 351186868)
20. D'hooge J, Heimdal A, Jamal F, et al. Regional strain and strain rate measurements by cardiac ultrasound: principles, implementation and limitations. Eur J Echocardiogr 2000;1:154-70.
21. Olivieri NF, Nathan DG, MacMillan JH, et al. Survival in medically treated patients with homozygous beta-thalassemia. N Engl J Med 1994;331:574-8. (Pubitemid 24265699)
22. Modell B, Khan M, Darlison M. Survival in beta-thalassaemia major in the UK: data from the UK Thalassaemia Register. Lancet 2000;355:2051-2. (Pubitemid 30339248)
23. Borgna-Pignatti C, Cappellini MD, De Stefano P, et al. Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major. Blood 2006;107:3733-7.
24. Davis BA, Porter JB. Long-Term outcome of continuous 24-hour deferoxamine infusion via indwelling intravenous catheter in high-risk beta-thalassemia. Blood 2000;95:1229-36. (Pubitemid 30099831)
25. Pennell DJ, Berdoukas V, Karagiorga M. Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis. Blood 2006;107:3738-44.
26. Cogliandro T, Derchi G, Mancuso L, et al; Society for the Study of Thalassemia and Hemoglobinopathies (SoSTE). Guideline recommendations for heart complications in thalassemia major. J Cardiovasc Med 2008;9:515-25.
27. Vlachos A, Ball S, Dahl N, et al; Participants of Sixth Annual Daniella Maria Arturi International Consensus Conference. Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference. Br J Haematol 2008;142:859-76.
28. Mavrogeni SI, Markussis V, Kaklamanis L, et al. A comparison of magnetic resonance imaging and cardiac biopsy in the evaluation of heart iron overload in patients with b-thalassemia major. Eur J Haematol 2005;75:241-7. (Pubitemid 41153105)
29. Pepe A, Positano V, Santarelli MF, et al. Multislice multiecho T2* cardiovascular magnetic resonance for detection of the heterogeneous distribution of myocardial iron overload. J Magn Reson Imaging 2006;23:662-8.
30. Perifanis V, Christoforidis A, Vlachaki E, et al. Comparison of effects of different long-term iron-chelation regimens on myocardial and hepatic iron concentrations assessed with T2* magnetic resonance imaging in patients with β-thalassemia major. Int J Hematol 2007;86:385-9.
31. Anderson LJ, Westwood MA, Holden S, et al. Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance. Br J Haematol 2004;127:348-55. (Pubitemid 39468951)
32. Tanner ME, Galanello R, Dessi C, et al. A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance. Circulation 2007;115:1876-84. (Pubitemid 46598901)
33. Modell B, Khan M, Darlison M, et al. Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2008;10:42.
34. http://clinicaltrials.gov/ct2/results?term=T2* (accessed 19 May 2009).
35. Westwood MA, Anderson LJ, Firmin DN, et al. Interscanner reproducibility of cardiovascular magnetic resonance T2* measurements of tissue iron in thalassemia. J Magn Reson Imaging 2003;18:616-20. (Pubitemid 37345172)